Some injectable peptide-based medications are being studied and used under medical supervision for weight and metabolic health in Singapore. This comparison is for informational and educational purposes only. Suitability, safety, and availability in Singapore depend on regulatory approvals and individual medical assessment.
What is Semaglutide?
Semaglutide is a peptide medication that acts in a manner similar to GLP-1 (glucagon-like peptide-1), a hormone in the body. Mechanistically, it may affect processes such as stomach emptying and signaling of fullness under medical study.
What is Tirzepatide?
Tirzepatide acts on similar hormonal pathways and additionally on GIP (glucose-dependent insulinotropic polypeptide). Some research suggests it may affect appetite and metabolic function, but these effects vary and must be evaluated by a physician.
Semaglutide Vs Tirzepatide in Singapore: Key Differences
How These Medications Work
Both semaglutide and tirzepatide help regulate appetite and blood sugar, but they do so via slightly different hormonal pathways:
Semaglutide: acts on GLP-1 (glucagon-like peptide-1) receptors, which:
- Slow gastric emptying
- Signal satiety to the brain
- Promote insulin release when blood sugar is elevated
Tirzepatide: targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, offering a dual-action mechanism that may enhance appetite control and glucose regulation.
By slowing digestion and influencing hunger-related brain signals, both medications reduce appetite and help with portion control.
Approved Uses
The clinical indications differ slightly between the two medications:
- Semaglutide: Approved for chronic weight management in adults with obesity or those who are overweight with weight-related health conditions, when used alongside a reduced-calorie diet and increased physical activity. Regulatory approval status may vary by jurisdiction.
- Tirzepatide: Regulatory approval for weight management applications is still being evaluated in Singapore. Patients should consult their doctor regarding current local approval status and appropriate use.
Dosing and Administration
Although both medications are injectable, there are some differences in how they are prescribed and escalated:
- Semaglutide: Taken once weekly via subcutaneous injection. Starts at a low dose and gradually increases to reduce side effects
- Tirzepatide. Also administered weekly by injection. Follows a similar dose titration schedule
Both drugs are available in pre-filled pens designed for self-injection. Doses are adjusted based on individual response and tolerability.
Side Effects and Considerations
Both semaglutide and tirzepatide are generally well-tolerated, especially when started at lower doses and gradually increased. Some individuals may notice mild digestive adjustments during the first few weeks as their body adapts to treatment.
- Common to both medications: Temporary effects such as nausea, reduced appetite, or changes in bowel habits (e.g., diarrhoea) may occur early in the treatment course. These typically ease with time as the body becomes accustomed to the medication
- Semaglutide: Some individuals may experience mild fatigue or localised injection site sensitivity. In rare cases, more specific effects such as pancreatic or gallbladder concerns may be discussed with your healthcare provider if relevant
- Tirzepatide: A small number of patients may report constipation or mild abdominal sensations that usually resolve with time
Cost of Semaglutide and Tirzepatide in Singapore
Semaglutide costs depend on brand and dose: S$300–S$600/month
Tirzepatide is less widely available but is estimated at S$600–S$1500/month via private providers. Pricing may vary with supply constraints.
Which Treatment Might Be Right for You?
- Whether a medication is appropriate should be decided by a qualified medical professional, based on a full clinical assessment.
- The mechanisms of action differ; dual-pathway medications may have differing study data, side effect profiles, and availability.
- Cost, frequency of monitoring, tolerability, and medical history are important considerations.”
Your doctor will consider your medical history, treatment goals, and medication tolerance to determine the best fit.
Conclusion
Semaglutide and Tirzepatide are prescription medications that act on hormonal pathways to influence appetite and metabolic processes. While both are under medical use, their approved indications and availability may differ depending on regulatory status in Singapore.
Any decision to consider these medications should be made only after a full consultation with a qualified doctor, who will assess your health history, current medical needs, and suitability for treatment. Outcomes can vary widely between individuals, and these treatments should always be used under proper medical supervision.
If you’re exploring prescription-based solutions for weight or glucose management, book a consultation with our men’s health clinic in Singapore for a personalised treatment plan.
